Search research articles
Contact Us
Filters
Showing results (101-110 of 178) with videos related to
Page
of 18
Sort By:
Applied and Environmental Microbiology
|
December 20, 2011
Transcriptional analysis of a Dehalococcoides-containing microbial consortium reveals prophage activation
Alison S Waller, Laura A Hug, Kaiguo Mo, et al.
Plos One
|
April 16, 2014
New insights into Dehalococcoides mccartyi metabolism from a reconstructed metabolic network-based systems-level analysis of D. mccartyi transcriptomes
M Ahsanul Islam, Alison S Waller, Laura A Hug, et al.
Infection and Immunity
|
February 4, 2010
Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity
Romain Paillot, Carl Robinson, Karen Steward, et al.
Plos Pathogens
|
September 19, 2009
Getting to grips with strangles: an effective multi-component recombinant vaccine for the protection of horses from Streptococcus equi infection
Bengt Guss, Margareta Flock, Lars Frykberg, et al.
The American Review of Respiratory Disease
|
January 1, 1990
A rabbit model of pulmonary hypertension induced by the synthetic platelet-activating factor acetylglyceryl ether phosphorylcholine
J A Ohar, J A Pyle, K S Waller, et al.
Endocrinology
|
September 1, 1993
The endogenous inhibitor of protein kinase-C in the rat ovary is a protein phosphatase
K M Eyster, M S Waller, T L Miller, et al.
The ISME Journal
|
March 14, 2014
Classification and quantification of bacteriophage taxa in human gut metagenomes
Alison S Waller, Takuji Yamada, David M Kristensen, et al.
Msphere
|
November 7, 2017
Novel Genes Required for the Fitness of <i>Streptococcus pyogenes</i> in Human Saliva
Luchang Zhu, Amelia R L Charbonneau, Andrew S Waller, et al.
Molecular Biosystems
|
October 15, 2015
Characterisation of SEQ0694 (PrsA/PrtM) of Streptococcus equi as a functional peptidyl-prolyl isomerase affecting multiple secreted protein substrates
Felicia Ikolo, Meng Zhang, Dean J Harrington, et al.
Cancer Chemotherapy and Pharmacology
|
October 6, 2006
Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial
M B Jameson, B C Baguley, P Kestell, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 178) with videos related to
Sort By:
Page
of 18
Applied and Environmental Microbiology
|
December 20, 2011
Transcriptional analysis of a Dehalococcoides-containing microbial consortium reveals prophage activation
Alison S Waller, Laura A Hug, Kaiguo Mo, et al.
Plos One
|
April 16, 2014
New insights into Dehalococcoides mccartyi metabolism from a reconstructed metabolic network-based systems-level analysis of D. mccartyi transcriptomes
M Ahsanul Islam, Alison S Waller, Laura A Hug, et al.
Infection and Immunity
|
February 4, 2010
Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity
Romain Paillot, Carl Robinson, Karen Steward, et al.
Plos Pathogens
|
September 19, 2009
Getting to grips with strangles: an effective multi-component recombinant vaccine for the protection of horses from Streptococcus equi infection
Bengt Guss, Margareta Flock, Lars Frykberg, et al.
The American Review of Respiratory Disease
|
January 1, 1990
A rabbit model of pulmonary hypertension induced by the synthetic platelet-activating factor acetylglyceryl ether phosphorylcholine
J A Ohar, J A Pyle, K S Waller, et al.
Endocrinology
|
September 1, 1993
The endogenous inhibitor of protein kinase-C in the rat ovary is a protein phosphatase
K M Eyster, M S Waller, T L Miller, et al.
The ISME Journal
|
March 14, 2014
Classification and quantification of bacteriophage taxa in human gut metagenomes
Alison S Waller, Takuji Yamada, David M Kristensen, et al.
Msphere
|
November 7, 2017
Novel Genes Required for the Fitness of <i>Streptococcus pyogenes</i> in Human Saliva
Luchang Zhu, Amelia R L Charbonneau, Andrew S Waller, et al.
Molecular Biosystems
|
October 15, 2015
Characterisation of SEQ0694 (PrsA/PrtM) of Streptococcus equi as a functional peptidyl-prolyl isomerase affecting multiple secreted protein substrates
Felicia Ikolo, Meng Zhang, Dean J Harrington, et al.
Cancer Chemotherapy and Pharmacology
|
October 6, 2006
Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial
M B Jameson, B C Baguley, P Kestell, et al.
Page
of 18